Tissue thyroid hormone levels in critical illness.

CONTEXT Pronounced alterations in serum thyroid hormone levels occur during critical illness. T3 decreases and rT3 increases, the magnitudes of which are related to the severity of disease. It is unclear whether these changes are associated with decreased tissue T3 concentrations and, thus, reduced thyroid hormone bioactivity. PATIENTS AND STUDY QUESTIONS: We therefore investigated, in 79 patients who died after intensive care and who did or did not receive thyroid hormone treatment, whether total serum thyroid hormone levels correspond to tissue levels in liver and muscle. Furthermore, we investigated the relationship between tissue thyroid hormone levels, deiodinase activities, and monocarboxylate transporter 8 expression. RESULTS Tissue iodothyronine levels were positively correlated with serum levels, indicating that the decrease in serum T3 during illness is associated with decreased levels of tissue T3. Higher serum T3 levels in patients who received thyroid hormone treatment were accompanied by higher levels of liver and muscle T3, with evidence for tissue-specific regulation. Tissue rT3 and the T3/rT3 ratio were correlated with tissue deiodinase activities. Monocarboxylate transporter 8 expression was not related to the ratio of the serum over tissue concentration of the different iodothyronines. CONCLUSION Our results suggest that, in addition to changes in the hypothalamus-pituitary-thyroid axis, tissue-specific mechanisms are involved in the reduced supply of bioactive thyroid hormone in critical illness.

[1]  G. Van den Berghe,et al.  Serum 3,3',5'-triiodothyronine (rT3) and 3,5,3'-triiodothyronine/rT3 are prognostic markers in critically ill patients and are associated with postmortem tissue deiodinase activities. , 2005, The Journal of clinical endocrinology and metabolism.

[2]  J. Harney,et al.  The type 2 deiodinase A/G (Thr92Ala) polymorphism is associated with decreased enzyme velocity and increased insulin resistance in patients with type 2 diabetes mellitus. , 2005, The Journal of clinical endocrinology and metabolism.

[3]  J. Harney,et al.  Type 1 iodothyronine deiodinase is a sensitive marker of peripheral thyroid status in the mouse. , 2005, Endocrinology.

[4]  M. Iitaka.  [Nonthyroidal illness]. , 2005, Nihon rinsho. Japanese journal of clinical medicine.

[5]  A. Uitterlinden,et al.  Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation , 2004, The Lancet.

[6]  G. Van den Berghe,et al.  Endocrine and metabolic effects of growth hormone (GH) compared with GH-releasing peptide, thyrotropin-releasing hormone, and insulin infusion in a rabbit model of prolonged critical illness. , 2004, Endocrinology.

[7]  G. Van den Berghe.  How does blood glucose control with insulin save lives in intensive care? , 2004, The Journal of clinical investigation.

[8]  J. Harney,et al.  Endoplasmic reticulum-associated degradation of the human type 2 iodothyronine deiodinase (D2) is mediated via an association between mammalian UBC7 and the carboxyl region of D2. , 2003, Molecular endocrinology.

[9]  T. Visser,et al.  Identification of Monocarboxylate Transporter 8 as a Specific Thyroid Hormone Transporter* , 2003, Journal of Biological Chemistry.

[10]  G. Van den Berghe,et al.  Reduced activation and increased inactivation of thyroid hormone in tissues of critically ill patients. , 2003, The Journal of clinical endocrinology and metabolism.

[11]  G. Van den Berghe,et al.  The combined administration of GH‐releasing peptide‐2 (GHRP‐2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP‐2 alone , 2002, Clinical endocrinology.

[12]  P. Larsen,et al.  Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. , 2002, Endocrine reviews.

[13]  G. Van den Berghe.  Dynamic neuroendocrine responses to critical illness. , 2002, Frontiers in neuroendocrinology.

[14]  B. Bistrian,et al.  Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.

[15]  M Schetz,et al.  Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.

[16]  T. Visser,et al.  Plasma membrane transport of thyroid hormones and its role in thyroid hormone metabolism and bioavailability. , 2001, Endocrine reviews.

[17]  M. Bettendorf,et al.  Tri-iodothyronine treatment in children after cardiac surgery: a double-blind, randomised, placebo-controlled study , 2000, The Lancet.

[18]  M. Obregon,et al.  Tissue-specific patterns of changes in 3,5,3'-triiodo-L-thyronine concentrations in thyroidectomized rats infused with increasing doses of the hormone. Which are the regulatory mechanisms? , 1999, Biochimie.

[19]  G. Van den Berghe,et al.  Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotrophin and prolactin release in prolonged critical illness. , 1999, European journal of endocrinology.

[20]  L. D. De Groot.  Dangerous dogmas in medicine: the nonthyroidal illness syndrome. , 1999, The Journal of clinical endocrinology and metabolism.

[21]  F. Escobar del Rey,et al.  Regulation of Iodothyronine Deiodinase Activity as Studied in Thyroidectomized Rats Infused with Thyroxine or Triiodothyronine. , 1997, Endocrinology.

[22]  C. Gorman,et al.  Euthyroid sick syndrome: an overview. , 1997, Thyroid : official journal of the American Thyroid Association.

[23]  J. Harney,et al.  Molecular biological and biochemical characterization of the human type 2 selenodeiodinase. , 1996, Endocrinology.

[24]  M. Obregon,et al.  Replacement therapy for hypothyroidism with thyroxine alone does not ensure euthyroidism in all tissues, as studied in thyroidectomized rats. , 1995, The Journal of clinical investigation.

[25]  P. Rothwell,et al.  Prediction of outcome in intensive care patients using endocrine parameters. , 1995, Critical care medicine.

[26]  J. Eales,et al.  Characterization of 3,5,3'-triiodo-L-thyronine transport into hepatocytes isolated from juvenile rainbow trout (Oncorhynchus mykiss), and comparison with L-thyroxine transport. , 1994, General and comparative endocrinology.

[27]  M. Obregon,et al.  Thyroid hormones in tissues from fetal and adult rats. , 1994, Endocrinology.

[28]  D. Ferguson,et al.  Thyroid hormone metabolism. A comparative evaluation. , 1994 .

[29]  E. Krenning,et al.  The sick euthyroid syndrome: changes in thyroid hormone serum parameters and hormone metabolism , 1993, Clinical endocrinology.

[30]  M. Kaplan,et al.  Reduced tissue thyroid hormone levels in fatal illness. , 1993, Metabolism: clinical and experimental.

[31]  T. Visser,et al.  Transport and metabolism of iodothyronines in cultured human hepatocytes. , 1993, The Journal of clinical endocrinology and metabolism.

[32]  S. Kunitake,et al.  Mechanism of the heparin-induced increase in the concentration of free thyroxine in plasma. , 1987, The Journal of clinical endocrinology and metabolism.

[33]  G. Brent,et al.  Thyroxine therapy in patients with severe nonthyroidal illnesses and low serum thyroxine concentration. , 1986, The Journal of clinical endocrinology and metabolism.

[34]  P. Hamblin,et al.  Relationship between thyrotropin and thyroxine changes during recovery from severe hypothyroxinemia of critical illness. , 1986, The Journal of clinical endocrinology and metabolism.

[35]  M. Obregon,et al.  Effects of maternal hypothyroidism on the weight and thyroid hormone content of rat embryonic tissues, before and after onset of fetal thyroid function. , 1985, Endocrinology.

[36]  A. Mason,et al.  Hypermetabolic low triiodothyronine syndrome of burn injury , 1982, Critical care medicine.

[37]  V. Bacci,et al.  The relationship between serum triiodothyronine and thyrotropin during systemic illness. , 1982, The Journal of clinical endocrinology and metabolism.

[38]  K. Burman,et al.  Alterations in thyroid function in patients with systemic illness: the "euthyroid sick syndrome". , 1982, Endocrine reviews.

[39]  T. Visser,et al.  Characteristics of active transport of thyroid hormone into rat hepatocytes. , 1981, Biochimica et biophysica acta.

[40]  B. N. Premachandra,et al.  Radioimmunoassay of reverse triiodothyronine. , 1978, The Journal of clinical endocrinology and metabolism.

[41]  T. Visser,et al.  Radioimmunoassay of reverse tri-iodothyronine. , 1977, The Journal of endocrinology.

[42]  C. Irvine.  Concentration of thyroxine in cellular and extracellular tissues of the sheep and the rate of equilibration of labeled thyroxine. , 1974, Endocrinology.